Pharmaceutical companies, wholesalers, parallel importers, and pharmacies are facing European regulatory compliance deadlines that address serialisation of prescription drugs, compliance reporting, and product verification. There is significant work that needs to take place across the entire supply chain.

Time is short. Read this paper to get a better understanding of the law, resource requirements, and the serialization solution capabilities you’ll need to meet Falsified Medicine Directive requirements by the February 2019 deadline.

• Overview of the falsified medicines directive and delegated regulation
• A deeper look at the delegated regulation
• Complications of the Falsified Medicine Directive discussed